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TNFα can activate pathways leading 
to caspase-8-mediated apoptosis, 
as well as inflammatory pathways 
signaled by transcription factors. 
The adaptor protein RIP is a 
critical component for TNF receptor 
 (TNFR)-mediated activation of 
NF-κB, because deletion of the gene 
encoding RIP in mice prevents 
induction of NF-κB by TNFα and 
causes severe runting with early 
postnatal lethality []. Recently, it 
has been proposed that caspase 8 
and 0 associated RING protein-2 
(CARP2, also named RIFIFYLIN/
SAKURA) binds to the TNFR 
complex, leading to ubiquitylation 
and proteasome-mediated 
degradation of RIP, thereby limiting 
the level of NF-κB activated by TNFα 
[2]. However, our experiments in 
mice lacking the Rififylin/Carp2 gene 
question this conclusion, because 
levels of RIP and induction of NF-κB 
by TNFα are normal in the absence  
of CARP2.
To validate the model proposed by 
Liao et al. [2], which was based on 
the overexpression of CARP2 and 
knockdown of CARP2 using short 
hairpin RNAs (shRNAs), we created 
mice in which the genes for Rififylin/
Carp2 were deleted by homologous 
recombination (Figure S  
in Supplemental Data, published 
with this article online). In addition, 
to examine the effects of CARP2 
overexpression, we infected D645 
glioma cells with a lentiviral vector 
encoding FLAG–CARP2 under the 
control of a 4-hydroxytamoxifen-
inducible promoter [3,4]. Consistent 
with a recent report [5], induction of 
FLAG–CARP2 expression resulted 
in the proteasome-mediated loss of 
endogenous p53 (Figure S2A,B).
Correspondences We found that Rififylin/Carp2-deficient knockout mice were born 
at expected Mendelian ratios, were 
healthy and displayed no overt 
phenotype, and exhibited normal 
fertility (Figure S and Table S). This 
contrasts with both RIP-deficient 
mice and mice lacking several 
proteins implicated in K48- and/
or K63-linked ubiquitylation and 
regulation of TNFR–RIP signaling 
[,3,6–4]. Isolated wild-type (WT) 
murine embryonic fibroblasts (MEFs) 
expressed readily detectable levels of 
CARP2 mRNA, while MEFs isolated 
from several independent Rififylin/
Carp2-deficient embryos did not 
(Figure S2C). 
Knockdown of CARP2 in 293T cells 
by transient transfection with CARP2-
targeting shRNA was reported to 
enhance activation of NF-κB by TNFα 
[2]. Consistent with this, Liao et al.  
[2] also reported that overexpression 
of FLAG–CARP2 prevented TNFα  
from activating NF-κB, and this 
correlated with CARP2-mediated  
RIP degradation. 
In Rififylin/Carp2-deficient MEFs, 
however, we found that both high 
(00 ng/ml) and low (0 ng/ml) doses 
of TNFα induced phosphorylation 
of p65, the degradation of IκB, and 
the subsequent NF-κB dependent 
restoration of IκB with the same 
kinetics as in WT MEFs (Figure A,B 
and Figure S2D). In addition, induction 
of FLAG–CARP2 overexpression in 
D645 cells did not interfere with  
TNFα-induced degradation and 
subsequent NF-κB-dependent 
induction of IκB (Figure C). 
If endosomal-localised CARP2 
acts as an E3 ligase for the minor 
pool of total RIP recruited to TNFR 
endocytic vesicles, as Liao et al. [2] 
suggested, one would not expect 
total cellular pools of cytosolic 
RIP to be degraded upon CARP2 
overexpression. However, CARP2 
overexpression depletes cellular 
endogenous p53 [5] (Figure S2A,B) 
and Liao et al. [2] demonstrated 
that overexpressed CARP2 resulted 
in a significant loss of cytosolic 
overexpressed RIP in 293T cells. 
We therefore asked whether 
overexpressed CARP2 could deplete 
endogenous RIP, and whether this 
would be reflected by increased RIP 
levels in Rififylin/Carp2-deficient 
MEFs. 
We observed that cellular RIP 
levels were the same in WT and Rififylin/Carp2-deficient MEFs 
(Figure D). When FLAG–CARP2 
overexpression was induced in D645 
cells, or FLAG–CARP2 and GFP–
CARP2 were transiently transfected 
in 293T cells, endogenous RIP 
levels were also not altered, and no 
difference was observed in the ability 
of TNFα to induce the NF-κB target 
gene A20 (Figure S2E,F). Importantly, 
immunoprecipitation experiments 
using Fc–TNFα demonstrated that 
TNFR-associated RIP levels and 
RIP ubiquitylation following TNFα 
treatment were similar between 
WT and Rififylin/Carp2-deficient 
MEFs (Figure E and Figure S2G,H), 
suggesting that even TNFR-
associated RIP and its modification 
is not substantially affected by the 
loss of CARP2. Deletion of CARP2 
also had no significant impact on 
cellular sensitivity to induction of 
apoptosis by TNFα alone or TNFα 
plus cycloheximide (data not  
shown).
We also assessed the global 
activation of NF-κB using lentiviral 
GFP and destabilized-luciferase 
NF-κB reporter assays. Consistent 
with the results above, we observed 
no significant difference in the total 
level of NF-κB activated between 
TNFα-treated WT and Rififylin/Carp2-
deficient MEFs (Figure F,G). Induction 
of FLAG–CARP2 in D645 cells also 
had no significant impact on the 
level of NF-κB induced by TNFα, as 
measured by either reporter assay 
(Figure F,G). 
To confirm these results we 
compared levels of NF-κB-activated 
target gene expression in WT and 
Rififylin/Carp2-deficient MEFs 
following TNFα treatment for  
24 hours. Using RT-PCR, no  
significant differences in TNFα-
mediated induction of cIAP2, IκB 
and A20 expression were detected 
between Rififylin/Carp2-deficient and 
WT MEFs (Figure H). 
Collectively, these results suggest 
that genetic deletion of Rififylin/
Carp2 has no significant impact 
on the induction or regulation of 
NF-κB induced by TNFα. While 
it remains possible that RIP is 
a bona fide target for CARP2 E3 
ubiquitin ligase activity, the role of 
CARP2 in the TNFR–RIP pathway 
appears minimal. It is noteworthy 
that functional redundancy may 
exist between different CARP-family 
members and that removal of both 
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Figure . Requirement for CARP2 for TNFα-
 induced NF-κB.
(A) Loss of CARP2 does not influence TNFα-
induced phosphorylation of p65. Wild-type (WT) 
and Carp2/Rififylin-deficient MEFs were incu-
bated with 00 ng/ml of Fc–TNFα for the indicat-
ed times and analysed for phosphorylation of 
p65 (P-p65) by western blotting. Similar results 
were observed with a lower (0 ng/ml) dose 
of Fc–TNFα (Figure S2D). (B) Carp2/Rififylin-
 deficient cells show normal IκBα degradation 
and NF-κB-dependent IκB recovery in response 
to TNFα. WT or Carp2/Rififylin-deficient MEFs 
were treated with Fc–TNFα (00 ng/ml) for the 
indicated times and IκBα levels examined by 
western blotting. Similar results were observed 
with a lower (0 ng/ml) dose of Fc–TNFα (Fig-
ure S2D). (C) Inducible CARP2 overexpression 
does not influence IκBα degradation or NF-κB-
dependent IκB recovery in response to TNFα. 
Stable FLAG–CARP2 inducible D645 cells were 
induced for 24 h and then treated with Fc–TNFα 
(00 ng/ml) for the indicated times and IκBα lev-
els were examined in the absence or presence 
of FLAG–CARP2. (D) Endogenous RIP protein 
levels are normal in Carp2/Rififylin-deficient 
cells. Five independent WT (C2+/+) or Carp2/
Rififylin-deficient (C2–/–) primary MEF lines were 
treated with or without Fc–TNFα (00 ng/ml) for 
30 min and endogenous RIP levels analysed 
by western blotting. (E) TNFR-associated RIP 
modification is similar in WT and Carp2/Rififylin-
deficient MEFs. Fc–TNFα was used to immuno-
precipitate TNFR and associated RIP at the 
indicated times following Fc–TNFα treatment. 
The immunoprecipitated TNFR complex was 
analysed by western blotting with the indicated 
antibodies. Time 0 represents cells where Fc–
TNFα was added after cells were lysed. The ma-
jority of TNFR resides intracellularly and only 
a small portion is accessible to Fc–TNFα when 
applied to intact, live MEFs: compare anti-TNF 
and anti-TNFR blots at time 0 with time 5 and 
60 min. The experiment was repeated on inde-
pendent WT and Carp2/Rififylin-deficient MEF 
lines with the same result (Figure S2G). Repre-
sentative western blots of the cell lysates used 
for these immunoprecipitation experiments are 
shown in Figure S2H. RIPU: unmodified RIP. 
RIPM: modified (ubiquitylated) RIP. (F,G) TNFα 
induction of NF-κB reporter activity is normal in Carp2/Rififylin-deficient and CARP2-overexpressing cell lines. (F) WT and Carp2/Rififylin-deficient 
MEFs (left graph) or stable FLAG–CARP2-inducible D645 cells (right graph) were infected with a lentiviral destabilised-luciferase NF-κB reporter. Cells 
were treated with Fc–TNFα (00 ng/ml) and reporter activity measured 24 h later and depicted as fold change in reporter activity relative to untreated 
cells. Error bars represent SD of at least three independent clones. (G) Cells were treated in the same manner as in (F), except they were infected with 
an NF-κB–GFP reporter plasmid and NF-κB activation assessed by flow cytometry. (H) NF-κB target gene regulation in WT and Carp2/Rififylin-defi-
cient cells. WT and two independent Carp2/Rififylin-deficient MEF cell lines were treated with Fc–TNFα (00 ng/ml) for 24 h and the RNA extracted and 
RT-PCR performed for the indicated transcripts. 
 
 CARP2 and CARP might be required 
for a role in TNFR function to 
become apparent. 
Supplemental Data
Supplemental data are available at http://
www.current-biology.com/supplemental/
S0960-9822(08)0557-.
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be able to compensate for the loss of 
CARP2. To investigate whether CARP 
can function as an E3 for internalized 
RIP, we purified endocytosed  
TNFR complexes and detected 
substantial amounts of endogenous 
CARP as early as 5 min  
after internalization, which lasted 
for almost 30 min (Figure C). We 
also found that RIP and CARP 
co-immunoprecipitated after TNFα 
stimulation or when co-expressed in 
the absence of stimulation (Figure D 
and data not shown). Moreover, 
in a cell-free system recombinant 
CARP catalyzed the transfer of 
ubiquitin (methylated) to purified RIP 
(Figure SA in Supplemental Data, 
published with this article online), and 
in cells exogenous CARP promoted 
ubiquitination of RIP with K48-linked 
chains (Figure E). Furthermore, in co-
transfection experiments RIP protein 
was downregulated in the presence 
of CARP and its loss was reversed 
by treatment with the proteasome 
inhibitor lactacystin (Figure SB). 
Importantly, we found that knockdown 
of CARP increased TNFR-associated 
ubiquitinated RIP (Figure F). These 
results demonstrate that CARP, like 
CARP2, can promote proteasomal 
degradation of internalized RIP. 
In agreement with these findings, 
overexpression of CARP inhibited 
IκBα degradation and IL-6 production in 
an E3-dependent manner (Figure G,H). 
Transfection with shRNA directed 
against two separate regions of CARP 
enhanced the increase in TNFα-induced 
NF-κB reporter activity, and this was 
neutralized with the expression of 
shRNA-resistant but not wild-type 
CARP (Figure I and Figure SC,D). 
For technical reasons, attempts to 
knock down the expression of both 
CARPs simultaneously have thus far 
failed to reduce the level of each to 
that achieved with single knockdowns. 
These findings, along with earlier 
published results, demonstrate that 
both CARP and CARP2 are E3s that 
target RIP and apical caspases and 
affect TNF signaling in a similar manner. 
Thus, tissue distribution and similarities 
in function suggest that CARP could 
compensate for the loss of CARP2 in 
knockout mice. 
We previously found that knockdown 
of CARP2 in tumor cell lines increased 
receptor-associated ubiquitinated RIP, 
having a maximum effect 5 min after 
stimulation, and modestly delayed 
IκBα recovery (Figure H and 4F in 
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Tumor necrosis factor α (TNFα)-initiated 
biological responses are regulated by 
internalization of the receptor signaling 
complex and its fusion with components 
of several endocytic compartments []. 
We have recently reported that CARP2 is 
constitutively associated with cytosolic 
membrane vesicles that fuse with the 
internalized TNF receptor  (TNFR) 
signaling complex, and that it functions 
as a ubiquitin protein ligase (E3) for RIP, 
an obligate signaling intermediary for  
NF-κB activation [2]. It has also been 
shown that CARP2 and its homolog 
CARP function as E3s for caspase-8 
and -0, and that knockdown via short 
hairpin RNAs (shRNAs) of CARP or 
CARP2 expression enhances TNFα-
induced caspase activation and cell 
death [3]. 
In this issue of Current Biology, 
Ahmed et al. [4] report that CARP2-
deficient mice develop normally and 
have no changes in TNF-induced 
activation of NF-κB or apoptosis. They 
suggest that this could be because of 
the functional redundancy that may 
exist between CARP2 and the other 
CARP family member, CARP. Here 
we show that CARP, like CARP2, 
functions as an E3 for RIP and affects 
NF-κB activation. CARP and CARP2 
have 43% identity at the amino-acid 
level and each contains a RING domain 
and a FYVE domain, the latter targeting 
the protein to membrane compartments 
(Figure A) [3,5]. Western blot analysis 
for CARP expression detected CARP2 
in five and CARP in nine of the thirteen 
normal tissues tested (Figure B). This 
is in contrast to the reported ubiquitous 
expression of both genes at the mRNA 
level [3,5]. The multiple band pattern 
(from 37–45 kDa) of CARP reflects 
post-translational modifications, such 
as lipidation, and agrees with reported 
observations with rat CARP [5]. 
Interestingly, CARP expression was 
detected in all the tissues that express 
CARP2, suggesting that CARP might of A20 downregulate NF-kappaB signalling. 
Nature 430, 694–699.
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